AstraZeneca selects Spotfire as R&D-wide e-analytics platform
Spotfire's solutions are designed to enable organizations around the world to improve the efficiency, the speed and the accuracy of their decision-making processes by advancing both individual and networked analysis.
"Spotfire's decision analytics technology has been used by AstraZeneca for several years with excellent results," said Goran Wennberg, Global IS Manager of Discovery at AstraZeneca. "This agreement provides us with the ability to now deploy these solutions globally to help us maximize the benefits of the research informatics infrastructure that we've implemented. We have aggressive goals for R&D productivity, and our relationship with Spotfire will help us to provide our staff with the tools to achieve them."
"AstraZeneca is a longstanding customer that has been an outstanding partner for Spotfire," said Christopher Ahlberg, CEO of Spotfire. "This agreement will allow AstraZeneca to build and deploy a world-leading decision making platform, and we look forward to continuing to work closely with them."